Global Human Vaccines Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Human Vaccines market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Human Vaccines market.
Major Players in the Human Vaccines market are:
Merck
Sinovac
Emergent Biosolutions
Seqirus
Bavarian Nordic
Bharat Biotech
GlaxoSmithKline (GSK)
Biological E. Limited
Pfizer
Panacea Biotec
Sanofi Pasteur
Mitsubishi Tanabe Pharma
Serum Institute of India
AstraZeneca
Valneva
On the basis of types, the Human Vaccines market is primarily split into:
Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
COVID-19
Others
On the basis of applications, the market covers:
Adult Vaccines
Pediatric Vaccines
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Human Vaccines Market Overview
- 1.1 Product Overview and Scope of Human Vaccines Market
- 1.2 Human Vaccines Market Segment by Type
- 1.2.1 Global Human Vaccines Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Human Vaccines Market Segment by Application
- 1.3.1 Human Vaccines Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Human Vaccines Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Human Vaccines (2017-2029)
- 1.5.1 Global Human Vaccines Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Human Vaccines Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Human Vaccines Industry
- 1.7 Impact of Carbon Neutrality on the Human Vaccines Industry
- 2 Human Vaccines Market Upstream and Downstream Analysis
- 2.1 Human Vaccines Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Human Vaccines Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Merck
- 3.1.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Human Vaccines Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Sinovac
- 3.2.1 Sinovac Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Human Vaccines Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Emergent Biosolutions
- 3.3.1 Emergent Biosolutions Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Human Vaccines Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Seqirus
- 3.4.1 Seqirus Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Human Vaccines Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Bavarian Nordic
- 3.5.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Human Vaccines Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Bharat Biotech
- 3.6.1 Bharat Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Human Vaccines Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 GlaxoSmithKline (GSK)
- 3.7.1 GlaxoSmithKline (GSK) Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Human Vaccines Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Biological E. Limited
- 3.8.1 Biological E. Limited Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Human Vaccines Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Pfizer
- 3.9.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Human Vaccines Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Panacea Biotec
- 3.10.1 Panacea Biotec Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Human Vaccines Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 Sanofi Pasteur
- 3.11.1 Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Human Vaccines Market Performance (2017-2022)
- 3.11.4 Business Overview
- 3.12 Mitsubishi Tanabe Pharma
- 3.12.1 Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.12.2 Product Profiles, Application and Specification
- 3.12.3 Human Vaccines Market Performance (2017-2022)
- 3.12.4 Business Overview
- 3.13 Serum Institute of India
- 3.13.1 Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.13.2 Product Profiles, Application and Specification
- 3.13.3 Human Vaccines Market Performance (2017-2022)
- 3.13.4 Business Overview
- 3.14 AstraZeneca
- 3.14.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.14.2 Product Profiles, Application and Specification
- 3.14.3 Human Vaccines Market Performance (2017-2022)
- 3.14.4 Business Overview
- 3.15 Valneva
- 3.15.1 Valneva Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.15.2 Product Profiles, Application and Specification
- 3.15.3 Human Vaccines Market Performance (2017-2022)
- 3.15.4 Business Overview
- 4 Global Human Vaccines Market Landscape by Player
- 4.1 Global Human Vaccines Sales and Share by Player (2017-2022)
- 4.2 Global Human Vaccines Revenue and Market Share by Player (2017-2022)
- 4.3 Global Human Vaccines Average Price by Player (2017-2022)
- 4.4 Global Human Vaccines Gross Margin by Player (2017-2022)
- 4.5 Human Vaccines Market Competitive Situation and Trends
- 4.5.1 Human Vaccines Market Concentration Rate
- 4.5.2 Human Vaccines Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Human Vaccines Sales, Revenue, Price Trend by Type
- 5.1 Global Human Vaccines Sales and Market Share by Type (2017-2022)
- 5.2 Global Human Vaccines Revenue and Market Share by Type (2017-2022)
- 5.3 Global Human Vaccines Price by Type (2017-2022)
- 5.4 Global Human Vaccines Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Human Vaccines Sales, Revenue and Growth Rate of Pneumococcal (2017-2022)
- 5.4.2 Global Human Vaccines Sales, Revenue and Growth Rate of Influenza (2017-2022)
- 5.4.3 Global Human Vaccines Sales, Revenue and Growth Rate of Hepatitis (2017-2022)
- 5.4.4 Global Human Vaccines Sales, Revenue and Growth Rate of HPV (2017-2022)
- 5.4.5 Global Human Vaccines Sales, Revenue and Growth Rate of Meningococcal (2017-2022)
- 5.4.6 Global Human Vaccines Sales, Revenue and Growth Rate of Rotavirus (2017-2022)
- 5.4.7 Global Human Vaccines Sales, Revenue and Growth Rate of Measles (2017-2022)
- 5.4.8 Global Human Vaccines Sales, Revenue and Growth Rate of Typhoid (2017-2022)
- 5.4.9 Global Human Vaccines Sales, Revenue and Growth Rate of Combination (2017-2022)
- 5.4.10 Global Human Vaccines Sales, Revenue and Growth Rate of COVID-19 (2017-2022)
- 5.4.11 Global Human Vaccines Sales, Revenue and Growth Rate of Others (2017-2022)
- 6 Global Human Vaccines Market Analysis by Application
- 6.1 Global Human Vaccines Consumption and Market Share by Application (2017-2022)
- 6.2 Global Human Vaccines Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Human Vaccines Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Human Vaccines Consumption and Growth Rate of Adult Vaccines (2017-2022)
- 6.3.2 Global Human Vaccines Consumption and Growth Rate of Pediatric Vaccines (2017-2022)
- 6.3.3 Global Human Vaccines Consumption and Growth Rate of Others (2017-2022)
- 7 Global Human Vaccines Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Human Vaccines Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Human Vaccines Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Human Vaccines Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Human Vaccines Market Forecast (2022-2029)
- 8.1 Global Human Vaccines Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Human Vaccines Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Human Vaccines Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Human Vaccines Price and Trend Forecast (2022-2029)
- 8.2 Global Human Vaccines Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Human Vaccines Sales and Revenue Forecast (2022-2029)
- 8.3 Global Human Vaccines Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Human Vaccines Revenue and Growth Rate of Pneumococcal (2022-2029)
- 8.3.2 Global Human Vaccines Revenue and Growth Rate of Influenza (2022-2029)
- 8.3.3 Global Human Vaccines Revenue and Growth Rate of Hepatitis (2022-2029)
- 8.3.4 Global Human Vaccines Revenue and Growth Rate of HPV (2022-2029)
- 8.3.5 Global Human Vaccines Revenue and Growth Rate of Meningococcal (2022-2029)
- 8.3.6 Global Human Vaccines Revenue and Growth Rate of Rotavirus (2022-2029)
- 8.3.7 Global Human Vaccines Revenue and Growth Rate of Measles (2022-2029)
- 8.3.8 Global Human Vaccines Revenue and Growth Rate of Typhoid (2022-2029)
- 8.3.9 Global Human Vaccines Revenue and Growth Rate of Combination (2022-2029)
- 8.3.10 Global Human Vaccines Revenue and Growth Rate of COVID-19 (2022-2029)
- 8.3.11 Global Human Vaccines Revenue and Growth Rate of Others (2022-2029)
- 8.4 Global Human Vaccines Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Human Vaccines Consumption Value and Growth Rate of Adult Vaccines (2022-2029)
- 8.4.2 Global Human Vaccines Consumption Value and Growth Rate of Pediatric Vaccines (2022-2029)
- 8.4.3 Global Human Vaccines Consumption Value and Growth Rate of Others (2022-2029)
- 8.5 Human Vaccines Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Human Vaccines Market Drivers Analysis
- 9.2 Human Vaccines Market Restraints and Challenges
- 9.3 Human Vaccines Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Human Vaccines Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Human Vaccines Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Human Vaccines Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook